A detailed history of Hrt Financial LP transactions in Veracyte, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 5,059 shares of VCYT stock, worth $152,377. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,059
Holding current value
$152,377
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$31.92 - $44.4 $161,483 - $224,619
5,059 New
5,059 $200,000
Q1 2023

May 12, 2023

SELL
$20.58 - $27.89 $678,954 - $920,118
-32,991 Reduced 37.02%
56,136 $1.25 Million
Q4 2022

Feb 10, 2023

BUY
$15.31 - $29.94 $933,940 - $1.83 Million
61,002 Added 216.9%
89,127 $2.11 Million
Q3 2022

Nov 14, 2022

BUY
$16.58 - $27.9 $466,312 - $784,687
28,125 New
28,125 $466,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.16B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.